Japanese Journal of Cancer and Chemotherapy最新文献

筛选
英文 中文
[A Case of Hyperammonemia Induced by 5‒FU in a Patient with Advanced Rectal Cancer]. [5-FU致晚期直肠癌高氨血症1例]。
Akira Ishii, Shinobu Tomochika, Yasuhiro Fujiwara, Hironori Tanaka, Mitsuo Nishiyama, Hiroto Matsui, Yoshitaro Shindo, Yukio Tokumitsu, Yusaku Watanabe, Noriko Maeda, Michihisa Iida, Hidenori Takahashi, Tatsuya Ioka, Hiroaki Nagano
{"title":"[A Case of Hyperammonemia Induced by 5‒FU in a Patient with Advanced Rectal Cancer].","authors":"Akira Ishii, Shinobu Tomochika, Yasuhiro Fujiwara, Hironori Tanaka, Mitsuo Nishiyama, Hiroto Matsui, Yoshitaro Shindo, Yukio Tokumitsu, Yusaku Watanabe, Noriko Maeda, Michihisa Iida, Hidenori Takahashi, Tatsuya Ioka, Hiroaki Nagano","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A 74‒year‒old male was diagnosed with advanced rectal cancer with bowel obstruction, and abscess formation. After sigmoid colostomy, FOLFOXIRI plus bevacizumab as preoperative chemotherapy was initiated. On day 3, during continuous administration of 5‒fluorouracil(5‒FU), the patient developed impaired consciousness accompanied by convulsive seizures and conjugate deviation. Electroencephalography(EEG)revealed no epileptic discharges, and imaging studies revealed no abnormality. A blood test showed a high ammonia level of 367μmol/L. In the absence of prior liver disease, the cause was suspected to be due to high‒dose 5‒FU. Administration of lactulose was started. The ammonia level normalized and the consciousness recovered quickly by the following day. It was thought that chemotherapy would be difficult to continue, and 1 month later, robot‒assisted low anterior resection and ileostomy were performed. The patient was discharged home without complication on postoperative day 13. We report this case of advanced rectal cancer in which administration of high‒dose 5‒FU caused hyperammonemia accompanied by impaired consciousness, with a literature review.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"53 2","pages":"123-125"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147310864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The Role of Anti‒Angiogenic Therapy in Tumor Immune Microenvironment]. [抗血管生成治疗在肿瘤免疫微环境中的作用]。
Minoru Kobayashi, Satoru Miura
{"title":"[The Role of Anti‒Angiogenic Therapy in Tumor Immune Microenvironment].","authors":"Minoru Kobayashi, Satoru Miura","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Angiogenesis is one of the hallmarks of cancer and has been recognized as a crucial process in tumor biology since the early stages of cancer research. Among the numerous angiogenesis factors, vascular endothelial growth factor(VEGF)is the primary driver of tumor angiogenesis and remains a central target in both basic research and drug development. Recent studies have revealed that VEGF not only promotes tumor growth through the formation of new blood vessels but also significantly impacts the tumor immune microenvironment. VEGF impairs dendritic cell maturation and antigen‒presenting capacity, promotes the mobilization and proliferation of immunosuppressive cell populations such as regulatory T cells and myeloid‒derived suppressor cells, and inhibitis the migration and function of effector T cells within the tumor. These immunomodulatory effects contribute to tumor immune evasion and may also affect the efficacy of immune‒checkpoint inhibitors (ICIs). This article reviews the effects of anti‒VEGF therapy on tumor immunity, the efficacy of its combination therapy with ICIs, and future prospects, based on findings from preclinical models and clinical studies.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"53 2","pages":"84-89"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147310886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of Thoracic Duct Injury Site via Inguinal Subcutaneous Injection of ICG in Esophagectomy-A Case Report. 食管切除术中腹股沟皮下注射ICG识别胸导管损伤部位1例。
Nobuaki Nakae, Tomonori Nakanoko, Manabu Yasuda, Takahiro Arai, Tomohide Kawashita, Kazuki Nishino, Mizuki Ninomiya
{"title":"Identification of Thoracic Duct Injury Site via Inguinal Subcutaneous Injection of ICG in Esophagectomy-A Case Report.","authors":"Nobuaki Nakae, Tomonori Nakanoko, Manabu Yasuda, Takahiro Arai, Tomohide Kawashita, Kazuki Nishino, Mizuki Ninomiya","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Thoracic duct injury is a serious complication of esophagectomy. Anatomical diversity can induce injury when esophagectomy is performed for esophageal cancer. Thoracic duct injury can sometimes be found after chylothorax occurs as a postoperative complication. Identifying the injured site in the thoracic duct is often difficult because of intensive inflammation due to chylothorax and anatomical diversity. In this case, we precisely identified the thoracic duct and sufficiently ligated the injured site using subcutaneous injection of indocyanine green(ICG)fluorescence, after the thoracic duct embolism using lipiodol was failed. Pooled lymphatic fluid fluoresced together with the illuminated thoracic duct, and the injured site could be clearly identified. The chylothorax disappeared after thoracic duct ligation, and the patient was discharged 40 days after esophagectomy. Subcutaneous injection around the inguinal lymph nodes can be beneficial procedure to identify injured site of thoracic duct from the fluoresced thoracic duct and pooled lymphatic fluid.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"53 2","pages":"99-102"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147310940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A Case of High‒Grade Appendiceal Mucinous Neoplasm Undergoing Ileocecal Resection]. 高级别阑尾黏液性肿瘤行回盲切除1例。
Soichiro Ogawa, Yoshiaki Kuriu, Yuji Fujita, Shun Ito, Ryo Takeda, Yoshihisa Matsumoto, Tomoki Konishi, Hisataka Matsuo, Shuhei Komatsu, Hisashi Ikoma, Kazuma Okamoto, Shusuke Sato, Yuko Sano, Yoji Urata, Eigo Otsuji
{"title":"[A Case of High‒Grade Appendiceal Mucinous Neoplasm Undergoing Ileocecal Resection].","authors":"Soichiro Ogawa, Yoshiaki Kuriu, Yuji Fujita, Shun Ito, Ryo Takeda, Yoshihisa Matsumoto, Tomoki Konishi, Hisataka Matsuo, Shuhei Komatsu, Hisashi Ikoma, Kazuma Okamoto, Shusuke Sato, Yuko Sano, Yoji Urata, Eigo Otsuji","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A 75‒year‒old man consulted our hospital with abdominal pain and fever. He was diagnosed as abscess‒forming appendicitis by contrast‒enhanced computed tomography(CT), and underwent conservative treatment and CT‒guided drainage. CT‒guided drainage revealed no abscess. Follow‒up contrast‒enhanced CT and MRI revealed a diagnosis of appendiceal mucinous neoplasm and peritoneal pseudomyxoma. Hence, the treatment strategy was operation. Intraoperative findings revealed mucus deposits in the right paracolic gutter and around the liver. The mucus was examined cytologically, but no malignant findings were detected. An ileocecal resection was performed. The pathological diagnosis was high‒grade appendiceal mucinous neoplasm(HAMN). The patient was discharged without postoperative complications. The patient was alive and recurrence‒free, 12 months after surgery. We report this rare case with a review of the literature.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"53 2","pages":"126-128"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147310785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Mitochondria in Cancer and Immunity]. [线粒体在癌症和免疫中的作用]。
Takahiro Taki, Teruya Morinaga, Yosuke Togashi
{"title":"[Mitochondria in Cancer and Immunity].","authors":"Takahiro Taki, Teruya Morinaga, Yosuke Togashi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Mitochondria are multifunctional organelles responsible not only for ATP production via oxidative phosphorylation but also for a wide range of cellular activities, including biosynthesis, redox regulation, signal transduction, and the control of apoptosis. In both cancer and immune cells, mitochondrial function plays various roles that extend beyond mere energy production. While cancer cells are known for the Warburg effect‒an enhanced glycolysis even in the presence of oxygen-they also actively utilize mitochondrial metabolism to fuel tumor progression. Furthermore, mutations in mitochondrial DNA(mtDNA) and alterations in nuclear genes encoding mitochondrial proteins contribute to tumorigenesis through various mechanisms, such as epigenetic modifications and the evasion of apoptosis. In immune cells, such as T cells and macrophages, mitochondrial metabolism is crucial for their differentiation and functional regulation. Key processes such as T cell activation, memory formation, and exhaustion, as well as macrophage functional polarization and inflammatory responses, are tightly linked to mitochondrial functional states. Recently, intercellular mitochondrial transfer within the tumor microenvironment has emerged as a significant phenomenon. Cancer cells can acquire mitochondria from surrounding cells to enhance their metabolic capacity and therapeutic resistance. Conversely, the transfer of mitochondria from cancer cells to T cells has been shown to suppress antitumor immune responses through metabolic dysfunction and homoplasmic replacement of T cell mtDNA. Based on these findings, therapeutic strategies targeting mitochondria are under investigation. These include inhibiting mitochondrial metabolism in cancer cells, boosting mitochondrial metabolism in T cells, and blocking intercellular mitochondrial transfer. Although preclinical studies have yielded promising results, further research is necessary to establish effective clinical therapies that can precisely modulate the complex metabolic interplay between cancer and immune cells.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"53 2","pages":"73-79"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147310796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A Case Report of Cecal Cancer with Port Site Recurrence and Right Inguinal Lymph Node Metastasis after Laparoscopic Ileo‒Cecal Resection]. [腹腔镜回盲肠切除术后盲肠癌Port部位复发及右侧腹股沟淋巴结转移1例报告]。
Keita Saito, Shiori Hatamoto, Shuta Hattori, Ryoma Yagi, Takahiro Sawatsubashi, Ryo Tanaka, Takashi Ishikawa, Hideki Nakatsuka, Kouei Nihei, Takashi Kato, Yoichi Ajioka
{"title":"[A Case Report of Cecal Cancer with Port Site Recurrence and Right Inguinal Lymph Node Metastasis after Laparoscopic Ileo‒Cecal Resection].","authors":"Keita Saito, Shiori Hatamoto, Shuta Hattori, Ryoma Yagi, Takahiro Sawatsubashi, Ryo Tanaka, Takashi Ishikawa, Hideki Nakatsuka, Kouei Nihei, Takashi Kato, Yoichi Ajioka","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A 74‒year‒old man was diagnosed with cecal cancer and performed ileo‒cecal resection with D3 lymphadenectomy. The postoperative pathological diagnosis was pT3N0M0, pStage Ⅱa. He was followed up without postoperative adjuvant chemotherapy. One year after the surgery, he developed pain in the port area of the right‒lower abdomen, and CT showed a mass with contrast enhancement at the port site. In addition, a lymph node mass was observed in the right inguinal region. Because of severe pain at the port site, an excisional biopsy of the abdominal wall was performed for both diagnostic and therapeutic purposes. The pathological diagnosis confirmed metastasis of cecal cancer. An excisional biopsy of a lymph node in the right inguinal region was performed, and pathological diagnosis was a metastasis of cecal cancer. Two years have passed without postoperative chemotherapy, and he remains alive without recurrence. The metastasis was thought to have metastasized lymphatically to the inguinal region from the port site recurrence. We report on the port site recurrence and lymphatic metastasis from the metastatic lesion.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"53 2","pages":"129-131"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147310867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Survey of the Effect of Adding Aprepitant at the First Treatment of Regimens Containing Carboplatin on Antiemetic Efficacy]. [含卡铂方案首次加用阿瑞吡坦对止吐效果的影响调查]。
Sari Shikibu, Koki Hashimoto, Wataru Toya, Hisanori Shimizu, Ryoko Sakai, Manabu Akazawa, Hiroyuki Kanao, Masakazu Yamaguchi
{"title":"[Survey of the Effect of Adding Aprepitant at the First Treatment of Regimens Containing Carboplatin on Antiemetic Efficacy].","authors":"Sari Shikibu, Koki Hashimoto, Wataru Toya, Hisanori Shimizu, Ryoko Sakai, Manabu Akazawa, Hiroyuki Kanao, Masakazu Yamaguchi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In the Guidelines for the Appropriate Use of Antiemetic Drugs published in 2023, antiemetic drugs for regimens containing carboplatin(CBDCA)with an area under the blood concentration time curve(AUC)of ≥4 is recommended for neurokinin 1(NK1)receptor antagonists. However, the antiemetic efficacy of aprepitant(APR)has not been adequately evaluated. Therefore, we investigated whether the addition of APR in gynecological cancer CBDCA/paclitaxel(PAC)therapy (TCb therapy)with or without APR influenced the overall treatment rate of emetic control, nausea control rate, emetic complete response(CR rate)and total control rate of nausea and vomiting(total complete: TC rate)were to be investigated. The results showed that the emesis control rate, nausea control rate, CR rate and TC rate were similar with and without concomitant APR. In other words, the addition of APR was not significant for nausea and vomiting in cancer chemotherapy during the first treatment of regimens including CBDCA in gynecological cancer patients.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"53 2","pages":"93-97"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147310954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Strategic Combination Approaches in Cancer Immunotherapy]. 肿瘤免疫治疗的策略组合方法。
Yuya Nishii, Yasushi Goto
{"title":"[Strategic Combination Approaches in Cancer Immunotherapy].","authors":"Yuya Nishii, Yasushi Goto","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Recent advances in immune checkpoint inhibitors(ICIs)have transformed cancer therapy, particularly in non‒small cell lung cancer. However, monotherapy achieves limited efficacy due to resistance and an immunosuppressive tumor microenvironment. Rational combination strategies‒chemotherapy, molecular targeted agents, dual checkpoint blockade, antibody‒drug conjugates(ADCs), and radiotherapy‒have shown promise in enhancing antitumor immunity. This review outlines the rationale and clinical evidence behind these combinations, emphasizing current challenges in biomarker development, immune‒related toxicity management, and optimal treatment sequencing for future personalized immunotherapy.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"53 2","pages":"90-92"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147310929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A Case of Liver Metastatic Recurrence of Transverse Colon Cancer Responding to Capecitabine+Bevacizumab Therapy]. [1例横断面结肠癌肝转移复发对卡培他滨+贝伐单抗治疗的响应]。
Hana Kawahata, Hajime Yokomizo, Sachiyo Okayama, Shunsuke Iwamoto, Shinichi Asaka, Takebumi Usui, Shunichi Shiozawa
{"title":"[A Case of Liver Metastatic Recurrence of Transverse Colon Cancer Responding to Capecitabine+Bevacizumab Therapy].","authors":"Hana Kawahata, Hajime Yokomizo, Sachiyo Okayama, Shunsuke Iwamoto, Shinichi Asaka, Takebumi Usui, Shunichi Shiozawa","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The patient was a 78‒year‒old woman. A liver tumor was detected on abdominal computed tomography(CT)performed for follow‒up after breast cancer surgery. Further examination revealed transverse colon cancer and liver metastases; therefore, transverse colon resection with D3 lymph node dissection and resection of the central 2 segments of the liver were performed. Four months later, liver recurrence was found on CT, which was diagnosed as unresectable, and chemotherapy was planned. Chemotherapy with capecitabine+oxaliplatin+bevacizumab was initiated. The capecitabine and oxaliplatin dosages were reduced due to adverse events. The CT scan showed PR; therefore, maintenance therapy with capecitabine+bevacizumab was initiated. The recurrent tumor continued to gradually shrink, and only a cystic lesion was observed on CT. CT performed 4 years and 1 month after the initiation of chemotherapy showed that the cystic lesion had almost disappeared from the liver. We believe that the factor contributing to the long‒term response in this case was the appropriate dose reduction and cessation of chemotherapy.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"53 2","pages":"121-122"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147310845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A Case of Robot-Assisted Thoracoscopic Extended Thymectomy for Thymoma Associated with Generalized Myasthenia Gravis]. 【机器人辅助胸腔镜下胸腺瘤扩展切除术合并广泛性重症肌无力一例】。
Tomoyuki Yamaguchi, Serina Akai, Nozomi Uozumi, Koji Yasuda, Hiroshi Shintani
{"title":"[A Case of Robot-Assisted Thoracoscopic Extended Thymectomy for Thymoma Associated with Generalized Myasthenia Gravis].","authors":"Tomoyuki Yamaguchi, Serina Akai, Nozomi Uozumi, Koji Yasuda, Hiroshi Shintani","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A 53-year-old male patient presented with dyspnea and was admitted with the diagnosis of bacterial pneumonia.His respiratory condition did not improve despite the resolution of fever with antibiotic therapy, and he was eventually diagnosed with thymoma associated with myasthenia gravis.The patient underwent robot-assisted thoracoscopic extended thymectomy under general anesthesia.The anterior mediastinal tissue was resected en bloc using 5 ports and the port-hopping function of the robotic system.The operation time was 264 min, and the blood loss was 55 g.Histopathologic examination led to the definitive diagnosis of type B2 thymoma.Postoperatively, muscle strength improved, oral intake resumed after extubation, and the patient was transferred to rehabilitation on day 35.Achieving adequate dissection without approaching from both the right and left sides is generally challenging in resecting mediastinal tissue via thoracoscopic extended thymectomy.The subxiphoid approach may pose similar limitations.However, in the present case, the use of the port-hopping function during robot-assisted surgery allowed scope insertion from various positions, enabling excellent visualization.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"53 1","pages":"60-62"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146004237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书